Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Universal Health Services, Inc (NYSE: UHS) closed the day trading at $205.96 down -0.52% from the previous closing price of $207.03. In other words, the price has decreased by -$0.52 from its previous closing price. On the day, 0.74 million shares were traded. UHS stock price reached its highest trading level at $205.98 during the session, while it also had its lowest trading level at $202.66.
Ratios:
For a better understanding of UHS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 113.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.29. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.60.
On November 03, 2025, Raymond James Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $270.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’25 when WARREN NIMETZ bought 3,817 shares for $223.30 per share.
Nimetz Warren J. sold 3,817 shares of UHS for $852,343 on Nov 11 ’25. The Director now owns 8,481 shares after completing the transaction at $223.30 per share. On Oct 29 ’25, another insider, SUSSMAN ELLIOT J MD MBA, who serves as the Director of the company, sold 965 shares for $225.70 each. As a result, the insider received 217,799 and left with 6,113 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UHS now has a Market Capitalization of 13107025920 and an Enterprise Value of 17994704896. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.79, and their Forward P/E ratio for the next fiscal year is 8.78. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.76 while its Price-to-Book (P/B) ratio in mrq is 1.79. Its current Enterprise Value per Revenue stands at 1.059 whereas that against EBITDA is 7.044.
Stock Price History:
The Beta on a monthly basis for UHS is 1.26, which has changed by 0.12418544 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, UHS has reached a high of $246.32, while it has fallen to a 52-week low of $152.33. The 50-Day Moving Average of the stock is -8.80%, while the 200-Day Moving Average is calculated to be 5.87%.
Shares Statistics:
Over the past 3-months, UHS traded about 695.05K shares per day on average, while over the past 10 days, UHS traded about 792130 shares per day. A total of 55.23M shares are outstanding, with a floating share count of 52.60M. Insiders hold about 15.81% of the company’s shares, while institutions hold 85.40% stake in the company. Shares short for UHS as of 1767139200 were 2063392 with a Short Ratio of 2.97, compared to 1764288000 on 1863811. Therefore, it implies a Short% of Shares Outstanding of 2063392 and a Short% of Float of 5.38.
Dividends & Splits
UHS’s forward annual dividend rate is 0.80, up from 0.8 a year ago. Against a Trailing Annual Dividend Yield of 0.0038641742. The stock’s 5-year Average Dividend Yield is 0.49. The current Payout Ratio is 4.76% for UHS, which recently paid a dividend on 2025-12-01 with an ex-dividend date of 2025-12-01. Stock splits for the company last occurred on 2009-12-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
. The current market rating for Universal Health Services, Inc (UHS) reflects the collective analysis of 14.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $5.29, with high estimates of $5.66 and low estimates of $4.88.
Analysts are recommending an EPS of between $21.92 and $21.51 for the fiscal current year, implying an average EPS of $21.76. EPS for the following year is $23.42, with 14.0 analysts recommending between $24.7 and $22.26.
Revenue Estimates
15 analysts predict $4.51B in revenue. The current quarter. It ranges from a high estimate of $4.57B to a low estimate of $4.45B. As of. The current estimate, Universal Health Services, Inc’s year-ago sales were $4.11BFor the next quarter, 15 analysts are estimating revenue of $4.34B. There is a high estimate of $4.41B for the next quarter, whereas the lowest estimate is $4.22B.
A total of 17 analysts have provided revenue estimates for UHS’s current fiscal year. The highest revenue estimate was $17.45B, while the lowest revenue estimate was $17.33B, resulting in an average revenue estimate of $17.39B. In the same quarter a year ago, actual revenue was $15.83BBased on 16 analysts’ estimates, the company’s revenue will be $18.25B in the next fiscal year. The high estimate is $18.68B and the low estimate is $17.88B.
